Mitoxantrone-induced extravasation.
Luke
Enza
E
Hematology/Oncology Medical Group of Orange, Orange, CA, USA. enza75@hotmail.com <enza75@hotmail.com>
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000175:diagnosis* / Q000451:nursing* / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy; D009336:Necrosis; D012307:Risk Factors; D013518:Surgery, Plastic
D000970:Antineoplastic Agents; D008942:Mitoxantrone